US to provide Bavarian Nordic's vaccine Jynneos to some at risk for monkeypox, CDC says

In response to the threat of a spread of monkeypox, the United States will provide doses of the Jynneos vaccine to some at-risk adults, the CDC said on Monday.

The U.S. has a stockpile of more than 1,000 doses of Jynneos, the CDC says. The two-dose vaccine is produced by Denmark’s Bavarian Nordic, which revealed last week that it had secured a contract to supply the shot to an unnamed country in Europe.